Population pharmacokinetic analysis for tisotumab vedotin in patients with locally advanced and/or metastatic solid tumors

• Asıl Yazarlar: Leonid Gibiansky (Yazar), Chaitali Passey (Yazar), Jenna Voellinger (Yazar), Rudy Gunawan (Yazar), William D. Hanley (Yazar), Manish Gupta (Yazar), Helen Winter (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wiley, 2022-10-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Tisotumab vedotin is an investigational antibody-drug conjugate (ADC) for treatment of solid tumors expressing tissue factor with accelerated approval from the US Food and Drug Administration for treatment of recurrent or metastatic cervical cancer with disease progression during or after c...